Effects of Bifidobacterium animalis subsp. lactis BB-12® on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trial

Table 3 Dietary intake of participants at baseline and after 4 weeks of the YS, PRE, POST, or CAPSULE treatment period^a,b

	BL (n = 30)	YS (n = 25)	PRE (n = 25)	POST (n = 26)	CAP (n = 26)	P Value*
Total calories, kcal/d	2472 ± 152	2224 ± 164	2338 ± 161	2092 ± 165	2321 ± 162	0.43
Carbohydrate, g/d	305 ± 21	287 ± 23	291 ± 22	270 ± 23	305 ± 21	0.79
Carbohydrate, % of energy	49.3 ± 1.5	50.5 ± 1.6	50.9 ± 1.6	51.8 ± 1.6	50.6 ± 1.6	0.75
Protein, g/d	97.3 ± 6.7	94.6 ± 7.3	95.8 ± 7.2	84.4 ± 7.3	93.3 ± 7.2	0.67
Protein, % of energy	15.8 ± 0.6	17.0 ± 0.7	16.7 ± 0.7	16.2 ± 0.7	16.0 ± 0.7	0.44
Fat, g/d	96.9 ± 6.1	79.2 ± 6.7	87.0 ± 6.5	75.9 ± 6.7	90.0 ± 6.6	0.09
Fat, % of energy	35.2 ± 1.2	32.9 ± 1.3	33.2 ± 1.3	32.5 ± 1.3	34.4 ± 1.3	0.33
Fiber, g/d	21.3 ± 1.7	21.9 ± 1.8	21.4 ± 1.8	21.0 ± 1.8	24.4 ± 1.8	0.39
Cholesterol, mg/d	310 ± 25	288 ± 27	276 ± 27	283 ± 27.4	262 ± 27	0.71

^aValues are means ± SDs; BL, baseline; YS, yogurt smoothie with no BB-12^®; PRE, yogurt smoothie with BB-12^® added pre-fermentation; POST, yogurt smoothie with BB-12^® post-fermentation
^bStatistical analyses were calculated using sex, treatment as between subject factor and randomization ID as the within-subject factor and age and BMI as covariates
*P values are for the main effect of treatment

ISSN: 1475-2891